A Phase 1 Study of ADI-001 in B Cell Malignancies

Clinical trial NCT04735471 · TERMINATED

Trial details

NCT number: NCT04735471
Sponsor: Adicet Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Follicular Lymphoma, Mantle-Cell Marginal Zone Lymphoma Primary Mediastinal B-cell Lymphoma Diffuse Large B Cell Lymphoma Lymphoma, Non-Hodgkin

Start date: 2021-03-04
Primary completion: 2025-02-03
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.